Skip to content

PCVX · Vaxcyte, Inc.

Healthcare · −2.5% on Oct 16

☆ Add to watchlist

Updated Oct 17 · 9 feeds behind: FDA drug approvals, 1 day, and 8 more · Every feed →

On this page

The market view

Price chart

The interactive PCVX chart (by TradingView) loads here.

Our take

None of our tested rules has picked PCVX yet.

The 0–100 score for PCVX
Members see one number for how strongly these rules agree on PCVX, and the day each rule fired. Better-tested rules count more, and so do different kinds of filings that point the same way.
See pricing →
Already a member? Sign in

Compare with this company’s history

Is disclosure activity unusual?

See how many different insiders or members of Congress reported purchases or sales of PCVX. Each bar covers 28 days, by disclosure date. Several trades by one person count once in each group and period.

Latest period: Sep 21, 2026–Oct 18, 2026 · UTC dates · today is excluded

Congress purchases

Sparse history

Only 2 of 12 earlier periods had activity. That is too little recurring activity to label this count unusual.

Latest 28 days
0
Earlier median
0
Earlier range
0–1
Distinct filers per 28 daysScale: 0–1
Oct 20, 2025Oct 18, 2026
Earlier periodsLatest 28 daysEarlier median 0

Who appears in the latest period?

No named filers on file for this period.

Up to three filers; one example disclosure each.

Inspect this period’s filings

The history behind this view

First stored company disclosure: Mar 28, 2025. Newest disclosure across this feed: Oct 15, 2026.

Earlier periods in the comparison: 12. Outlined periods are missing data, so they are left out of the comparison. The chart scale changes with the category.

Exact counts, dates and filings for all four categories
Insider purchases · Short history

Only 3 earlier periods are on file to compare with. We need at least 6 full periods before calling a count unusual. Earlier median: 0; range: 0–0.

Insider purchases: distinct filers in stored disclosures
Period and filingsFilersHistory
Oct 20, 2025–Nov 16, 2025—Unavailable
Nov 17, 2025–Dec 14, 2025—Unavailable
Dec 15, 2025–Jan 11, 2026—Unavailable
Jan 12, 2026–Feb 8, 2026—Unavailable
Feb 9, 2026–Mar 8, 2026—Unavailable
Mar 9, 2026–Apr 5, 2026—Unavailable
Apr 6, 2026–May 3, 2026—Unavailable
May 4, 2026–May 31, 2026—Unavailable
Jun 1, 2026–Jun 28, 20260Partial; excluded
Jun 29, 2026–Jul 26, 20260Within stored history
Jul 27, 2026–Aug 23, 20260Within stored history
Aug 24, 2026–Sep 20, 20260Within stored history
Sep 21, 2026–Oct 18, 2026Latest period0Within stored history
Insider sales · Short history

Only 3 earlier periods are on file to compare with. We need at least 6 full periods before calling a count unusual. Earlier median: 2; range: 1–4.

Insider sales: distinct filers in stored disclosures
Period and filingsFilersHistory
Oct 20, 2025–Nov 16, 2025—Unavailable
Nov 17, 2025–Dec 14, 2025—Unavailable
Dec 15, 2025–Jan 11, 2026—Unavailable
Jan 12, 2026–Feb 8, 2026—Unavailable
Feb 9, 2026–Mar 8, 2026—Unavailable
Mar 9, 2026–Apr 5, 2026—Unavailable
Apr 6, 2026–May 3, 2026—Unavailable
May 4, 2026–May 31, 2026—Unavailable
Jun 1, 2026–Jun 28, 20262Partial; excluded
Jun 29, 2026–Jul 26, 20262Within stored history
Jul 27, 2026–Aug 23, 20264Within stored history
Aug 24, 2026–Sep 20, 20261Within stored history
Sep 21, 2026–Oct 18, 2026Latest period2Within stored history
Congress purchases · Sparse history

Only 2 of 12 earlier periods had activity. That is too little recurring activity to label this count unusual. Earlier median: 0; range: 0–1.

Congress purchases: distinct filers in stored disclosures
Period and filingsFilersHistory
Oct 20, 2025–Nov 16, 20250Within stored history
Nov 17, 2025–Dec 14, 20250Within stored history
Dec 15, 2025–Jan 11, 20260Within stored history
Jan 12, 2026–Feb 8, 20260Within stored history
Feb 9, 2026–Mar 8, 20260Within stored history
Mar 9, 2026–Apr 5, 20260Within stored history
Apr 6, 2026–May 3, 20260Within stored history
May 4, 2026–May 31, 20260Within stored history
Jun 1, 2026–Jun 28, 20261Within stored history
Jun 29, 2026–Jul 26, 20260Within stored history
Jul 27, 2026–Aug 23, 20261Within stored history
Aug 24, 2026–Sep 20, 20260Within stored history
Sep 21, 2026–Oct 18, 2026Latest period0Within stored history
Congress sales · Sparse history

Only 0 of 12 earlier periods had activity. That is too little recurring activity to label this count unusual. Earlier median: 0; range: 0–0.

Congress sales: distinct filers in stored disclosures
Period and filingsFilersHistory
Oct 20, 2025–Nov 16, 20250Within stored history
Nov 17, 2025–Dec 14, 20250Within stored history
Dec 15, 2025–Jan 11, 20260Within stored history
Jan 12, 2026–Feb 8, 20260Within stored history
Feb 9, 2026–Mar 8, 20260Within stored history
Mar 9, 2026–Apr 5, 20260Within stored history
Apr 6, 2026–May 3, 20260Within stored history
May 4, 2026–May 31, 20260Within stored history
Jun 1, 2026–Jun 28, 20260Within stored history
Jun 29, 2026–Jul 26, 20260Within stored history
Jul 27, 2026–Aug 23, 20260Within stored history
Aug 24, 2026–Sep 20, 20260Within stored history
Sep 21, 2026–Oct 18, 2026Latest period0Within stored history
How to read this comparison

The median is the middle count in up to 12 earlier, non-overlapping 28-day periods; the range runs from the smallest to the largest count. The latest period is excluded from both. A comparison needs at least 6 earlier periods, including 3 with activity. The feed’s latest disclosure must be within 7 days of the current period’s end. This freshness check does not verify complete collection.

Insiders include individuals and reporting entities; only purchase and sale codes enter this view. Congress counts reporting members, including their disclosed family transactions. The same filer can appear in purchases and sales, so these categories should not be added into a net count.

These are stored disclosures, not a complete measure of trading. Reporting delays and collection gaps can change the comparison. More activity does not identify a motive or predict a stock’s return.

Company timeline

What has been happening?

May 1, 2026–Oct 16, 2026. Select a month in a category to inspect its records.

Company filings

Insiders

Public officials

FDA & trials

Company filings · Oct 2026

  1. Filed
  2. Record date
    FDA warning letter ↗

    8-K · mentioned before

  3. Filed
  4. Filed
  5. Filed
  6. Filed

2 more on file are not listed here.

All 37 records in this snapshot
  1. Record date
  2. Filed
  3. Record date
    FDA warning letter ↗

    8-K · mentioned before

  4. Filed
  5. Filed
  6. Filed
  7. Disclosed
    Elvia Cowan · Sale

    Transaction dated Oct 5, 2026

  8. Disclosed
    Jim Wassil · Sale

    Transaction dated Oct 5, 2026

  9. Filed
  10. Filed
  11. Filed
  12. Disclosed
    Jim Wassil · Sale

    Transaction dated Oct 1, 2026

  13. Disclosed
    Jim Wassil · Sale

    Transaction dated Oct 1, 2026

  14. Filed
  15. Disclosed
    Jim Wassil · Sale

    Transaction dated Sep 4, 2026

  16. Disclosed
    Jim Wassil · Sale

    Transaction dated Sep 9, 2026

  17. Filed
  18. Filed
  19. Disclosed
    Jim Wassil · Sale

    Transaction dated Sep 1, 2026

  20. Disclosed
    Jim Wassil · Sale

    Transaction dated Sep 1, 2026

  21. Disclosed
    Jim Wassil · Sale

    Transaction dated Sep 1, 2026

  22. Disclosed
    Jim Wassil · Sale

    Transaction dated Sep 1, 2026

  23. Disclosed
    Gilbert Ray Cisneros Jr · Purchase

    Transaction dated Jul 16, 2026

  24. Disclosed
    Andrew Guggenhime · Sale

    Transaction dated Aug 3, 2026

  25. Disclosed
    Andrew Guggenhime · Sale

    Transaction dated Aug 3, 2026

  26. Disclosed
    Harpreet S. Dhaliwal · Sale

    Transaction dated Aug 5, 2026

  27. Disclosed
    Jim Wassil · Sale

    Transaction dated Aug 3, 2026

  28. Disclosed
    Jim Wassil · Sale

    Transaction dated Aug 3, 2026

  29. Disclosed
    Grant Pickering · Sale

    Transaction dated Jul 27, 2026

  30. Disclosed
    Grant Pickering · Sale

    Transaction dated Jul 27, 2026

  31. Disclosed
    Grant Pickering · Sale

    Transaction dated Jul 27, 2026

  32. Disclosed
    Grant Pickering · Sale

    Transaction dated Jul 27, 2026

  33. Disclosed
    Grant Pickering · Sale

    Transaction dated Jul 27, 2026

  34. Disclosed
    Grant Pickering · Sale

    Transaction dated Jul 27, 2026

  35. Disclosed
    Andrew Guggenhime · Sale

    Transaction dated Jul 6, 2026

  36. Disclosed
    Jim Wassil · Sale

    Transaction dated Jul 1, 2026

  37. Disclosed
    Jim Wassil · Sale

    Transaction dated Jul 1, 2026

Month counts include every record on file. The lists show the newest records on this page. A dash means none on file that month. Trades use disclosure dates; contract dates follow the source record. Nearby events do not establish the cause of a price move.

Who's buying and selling · last 90 days

Congress

1 member bought, none sold · 1 Dem

  1. ▲ BUYGilbert Ray Cisneros Jr Dem · House · CAPCVX Vaxcyte, Inc.$1K–$15Kdisclosed Aug 14 · filed 29 days after the trade
See every Congress trade on PCVX →

Company insiders

0 buys · 9 sells (21 filed lots) · $6.3M sold

  1. ▼ SELLElvia Cowan SVP, Finance & CAOPCVX Vaxcyte, Inc.$1.6Mdisclosed Oct 7 · filed 2 days after the trade
  2. ▼ SELLJim Wassil EVP, Chief Scientific Ofc, COOPCVX Vaxcyte, Inc.$1.6Mdisclosed Oct 7 · filed 2 days after the trade
  3. ▼ SELLJim Wassil EVP, Chief Scientific Ofc, COOPCVX Vaxcyte, Inc.$5.4Kdisclosed Oct 2 · filed 1 day after the trade
  4. ▼ SELLJim Wassil EVP, Chief Scientific Ofc, COOPCVX Vaxcyte, Inc.$122Kdisclosed Oct 2 · filed 1 day after the trade
  5. ▼ SELLJim Wassil EVP, Chief Scientific Ofc, COOPCVX Vaxcyte, Inc.$84.5Kdisclosed Sep 9 · filed 5 days after the trade · late
  6. ▼ SELLJim Wassil EVP, Chief Scientific Ofc, COOPCVX Vaxcyte, Inc.$79.4Kdisclosed Sep 9 · filed the same day
  7. ▼ SELLJim Wassil Chief Operating OfficerPCVX Vaxcyte, Inc.$56.3Kdisclosed Sep 2 · filed 1 day after the trade
  8. ▼ SELLJim Wassil Chief Operating OfficerPCVX Vaxcyte, Inc.$43.8Kdisclosed Sep 2 · filed 1 day after the trade
  9. ▼ SELLJim Wassil Chief Operating OfficerPCVX Vaxcyte, Inc.$93.6Kdisclosed Sep 2 · filed 1 day after the trade
  10. ▼ SELLJim Wassil Chief Operating OfficerPCVX Vaxcyte, Inc.$18.6Kdisclosed Sep 2 · filed 1 day after the trade
See every insider trade on PCVX →

Filings & events

Company filings (8-K) 51

Events the company must report to the SEC within days — results, deals, departures, restatements.

What it files 8-Ks about

  • Quarterly or yearly results · item 2.029
  • Signed a major agreement · item 1.016
  • Other events · item 8.016
  • Directors or officers joined, left or got new pay · item 5.025
  • Shareholder vote results · item 5.074
  • Shared information with investors · item 7.013

Filing red flags 10

Warning signs in the company's own SEC filings — going-concern doubts, control weaknesses, staff comment letters, late filings, restatements, Wells notices, clinical holds, dividend cuts.

Planned insider sales (Form 144) 105

Notices insiders file before they sell certain shares, such as ones they got straight from the company.

10 in the last 90 days · 105 notices on file

The notices on file don't give the sale's size; each sale shows up under company insiders once it is reported.

5% owners (13D / 13G) 2

Investors who reported owning 5% or more — 13D for owners who may push for changes, 13G for owners who just hold.

Push for changes, or just hold?

  • 13G, just holds: 2 filings

Filed by Vanguard Capital Management LLC · T. Rowe Price Investment Management, Inc.

Biggest named funds (13F)

The largest PCVX holdings among the well-known funds whose quarterly 13F filings we read — opens here.

Every disclosed trade on PCVX

  1. ▼ SELLElvia Cowan SVP, Finance & CAOPCVX Vaxcyte, Inc.$1.6Mdisclosed Oct 7 · filed 2 days after the trade
  2. ▼ SELLJim Wassil EVP, Chief Scientific Ofc, COOPCVX Vaxcyte, Inc.$1.6Mdisclosed Oct 7 · filed 2 days after the trade
  3. ▼ SELLJim Wassil EVP, Chief Scientific Ofc, COOPCVX Vaxcyte, Inc.$5.4Kdisclosed Oct 2 · filed 1 day after the trade
  4. ▼ SELLJim Wassil EVP, Chief Scientific Ofc, COOPCVX Vaxcyte, Inc.$122Kdisclosed Oct 2 · filed 1 day after the trade
  5. ▼ SELLJim Wassil EVP, Chief Scientific Ofc, COOPCVX Vaxcyte, Inc.$84.5Kdisclosed Sep 9 · filed 5 days after the trade · late
  6. ▼ SELLJim Wassil EVP, Chief Scientific Ofc, COOPCVX Vaxcyte, Inc.$79.4Kdisclosed Sep 9 · filed the same day
  7. ▼ SELLJim Wassil Chief Operating OfficerPCVX Vaxcyte, Inc.$56.3Kdisclosed Sep 2 · filed 1 day after the trade
  8. ▼ SELLJim Wassil Chief Operating OfficerPCVX Vaxcyte, Inc.$43.8Kdisclosed Sep 2 · filed 1 day after the trade
  9. ▼ SELLJim Wassil Chief Operating OfficerPCVX Vaxcyte, Inc.$93.6Kdisclosed Sep 2 · filed 1 day after the trade
  10. ▼ SELLJim Wassil Chief Operating OfficerPCVX Vaxcyte, Inc.$18.6Kdisclosed Sep 2 · filed 1 day after the trade
  11. ▲ BUYGilbert Ray Cisneros Jr Dem · House · CAPCVX Vaxcyte, Inc.$1K–$15Kdisclosed Aug 14 · filed 29 days after the trade
  12. ▼ SELLAndrew Guggenhime President and CFOPCVX Vaxcyte, Inc.$165Kdisclosed Aug 5 · filed 2 days after the trade
  13. ▼ SELLHarpreet S. Dhaliwal Chief Technical Ops OfficerPCVX Vaxcyte, Inc.$935Kdisclosed Aug 5 · filed the same day
  14. ▼ SELLAndrew Guggenhime President and CFOPCVX Vaxcyte, Inc.$374Kdisclosed Aug 5 · filed 2 days after the trade
  15. ▼ SELLJim Wassil Chief Operating OfficerPCVX Vaxcyte, Inc.$75.1Kdisclosed Aug 5 · filed 2 days after the trade
  16. ▼ SELLJim Wassil Chief Operating OfficerPCVX Vaxcyte, Inc.$46.1Kdisclosed Aug 5 · filed 2 days after the trade
  17. ▼ SELLGrant Pickering Chief Executive OfficerPCVX Vaxcyte, Inc.$13.7Kdisclosed Jul 28 · filed 1 day after the trade
  18. ▼ SELLGrant Pickering Chief Executive OfficerPCVX Vaxcyte, Inc.$654Kdisclosed Jul 28 · filed 1 day after the trade
  19. ▼ SELLGrant Pickering Chief Executive OfficerPCVX Vaxcyte, Inc.$42Kdisclosed Jul 28 · filed 1 day after the trade
  20. ▼ SELLGrant Pickering Chief Executive OfficerPCVX Vaxcyte, Inc.$21.1Kdisclosed Jul 28 · filed 1 day after the trade
  21. ▼ SELLGrant Pickering Chief Executive OfficerPCVX Vaxcyte, Inc.$34.5Kdisclosed Jul 28 · filed 1 day after the trade
  22. ▼ SELLGrant Pickering Chief Executive OfficerPCVX Vaxcyte, Inc.$247Kdisclosed Jul 28 · filed 1 day after the trade
  23. ▼ SELLJim Wassil Chief Operating OfficerPCVX Vaxcyte, Inc.$26.2Kdisclosed Jul 6 · filed 5 days after the trade · late
  24. ▼ SELLJim Wassil Chief Operating OfficerPCVX Vaxcyte, Inc.$347disclosed Jul 6 · filed 5 days after the trade · late
  25. ▼ SELLAndrew Guggenhime President and CFOPCVX Vaxcyte, Inc.$121Kdisclosed Jul 6 · filed the same day
See all 46 trades on PCVX →
People & votes

Which members of Congress traded PCVX, sponsored bills that touch it and voted on them — opens here.